Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology-Reference-Cited by-同舟云学术

Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

Published:2019-04 Issue:4 Volume:17 Page:367-402
ISSN:1540-1405
Container-title:Journal of the National Comprehensive Cancer Network
language:
Short-container-title:

Author:

Coit Daniel G.¹,Thompson John A.²,Albertini Mark R.³,Barker Christopher¹,Carson William E.⁴,Contreras Carlo⁵,Daniels Gregory A.⁶,DiMaio Dominick⁷,Fields Ryan C.⁸,Fleming Martin D.⁹,Freeman Morganna¹⁰,Galan Anjela¹¹,Gastman Brian¹²,Guild Valerie¹³,Johnson Douglas¹⁴,Joseph Richard W.¹⁵,Lange Julie R.¹⁶,Nath Sameer¹⁷,Olszanski Anthony J.¹⁸,Ott Patrick¹⁹,Gupta Aparna Priyanath²⁰,Ross Merrick I.²¹,Salama April K.²²,Skitzki Joseph²³,Sosman Jeffrey²⁰,Swetter Susan M.²⁴,Tanabe Kenneth K.²⁵,Wuthrick Evan²⁶,McMillian Nicole R.²⁷,Engh Anita M.²⁷

Affiliation:

1. 1Memorial Sloan Kettering Cancer Center;

2. 2Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance;

3. 3University of Wisconsin Carbone Cancer Center;

4. 4The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute;

5. 5University of Alabama at Birmingham Comprehensive Cancer Center;

6. 6UC San Diego Moores Cancer Center;

7. 7Fred & Pamela Buffett Cancer Center;

8. 8Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine;

9. 9St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center;

10. 10City of Hope National Medical Center;

11. 11Yale Cancer Center/Smilow Cancer Hospital;

12. 12Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute;

13. 13Aim at Melanoma;

14. 14Vanderbilt-Ingram Cancer Center;

15. 15Mayo Clinic Cancer Center;

16. 16The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;

17. 17University of Colorado Cancer Center;

18. 18Fox Chase Cancer Center;

19. 19Dana-Farber/Brigham and Women's Cancer Center;

20. 20Robert H. Lurie Comprehensive Cancer Center of Northwestern University;

21. 21The University of Texas MD Anderson Cancer Center;

22. 22Duke Cancer Institute;

23. 23Roswell Park Comprehensive Cancer Center;

24. 24Stanford Cancer Institute;

25. 25Massachusetts General Hospital Cancer Center;

26. 26Moffitt Cancer Center; and

27. 27National Comprehensive Cancer Network

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cutaneous melanoma have been significantly revised over the past few years in response to emerging data on immune checkpoint inhibitor therapies and BRAF-targeted therapy. This article summarizes the data and rationale supporting extensive changes to the recommendations for systemic therapy as adjuvant treatment of resected disease and as treatment of unresectable or distant metastatic disease.

Publisher

Harborside Press, LLC

Subject

Oncology

Cited by 291 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of Prognostic Factors for Non-Sentinel Lymph Node Metastasis in Patients Undergoing Sentinel Lymph Node Biopsy for Cutaneous Malignant Melanoma: Experience from a Reference Center in Turkey;Journal of Plastic, Reconstructive & Aesthetic Surgery;2024-02

2. A Narrative Review of Current Knowledge on Cutaneous Melanoma;Clinics and Practice;2024-01-26

3. Low incidence of BRAF and NRAS mutations in a population with a high incidence of melanoma;Virchows Archiv;2024-01-06

4. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU;Revista Española de Enfermedades Digestivas;2024

5. BCG and Autoimmunity;Infection and Autoimmunity;2024